💰The Funding Letter #1414: May 10

Bluejay Therapeutics, Hysata, Electric Hydrogen, and more...

May 10, 2024

Happy Friday! This exclusive edition of The Funding Letter comes to you from our headquarters in New York City. Have a great weekend!

Hit the Gong 🎉

Source: @sales_humor

Daily Deals 💸

🌎 Americas

Bluejay Therapeutics has developed therapeutic medicines that focus on reducing viral surface antigen monoclonal antibodies for the restoration of adaptive immunity and offer cures for people with viral and liver diseases, starting with CHB and CHD, enabling patients to improve their immunity and recover from infection. View on: LinkedIn.com | Sales Navigator.

New Funding Raised: $182M, Series C

Round Investors: Frazier Life Sciences (lead), Arkin Bio Ventures, RA Capital Management, T. Rowe Price

🚀Growth Focus: Accelerate the clinical development of BJT-778, as the treatment for HDV and support the progression of promising candidates in its robust pipeline for chronic hepatitis B.

HQ: San Francisco, CA

Industry: Biotechnology Research

Employee Count: 18 (⚡13% increase in last 6 months)

Aardvark Therapeutics operates small molecule therapeutics that offer a first-in-class oral composition that selectively disrupts hunger signaling, regulates energy homeostasis, and does not interfere with nutrient absorption, allowing clinicians with an effective and safe treatment for obesity-related diseases. View on: LinkedIn.com | Sales Navigator.

New Funding Raised: $85M, Series C

Round Investors: The Prader-Willi Syndrome Association – USA, Cormorant Asset Management, The Foundation for Prader-Willi Research, Walleye Capital

🚀Growth Focus: Support the advancement of ARD-101’s potential in combating obesity, alongside propelling other critical pipeline programs

HQ: San Diego, CA

Industry: Pharmaceutical Manufacturing

Employee Count: 14

Subscribe to TFL All-Access Tier to read the rest.

Become a paying subscriber of TFL All-Access Tier to get access to this post and other subscriber-only content.

Already a paying subscriber? Sign In.

A subscription gets you:

  • • Exclusive Access to The Funding Letter, delivering hundreds of leads to your inbox each month
  • • Searchable weekly, monthly, and annual datasets of funding announcement leads, so you can quickly find the most relevant data
  • • The hottest Sales Gigs in the industry, sourced from the fastest growing startups
  • • ..and much more to come!